{"entity":{"type":"insider","cik":"0001706399","url":"/insider/0001706399","json_url":"/insider/0001706399.json","name":"Chimovits Erez","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":11,"first":"2018-10-25","last":"2026-08-11","span_basis":"filed_date"},"name_variants":[{"name":"Chimovits Erez","source":"filing","n_filings":11,"first_seen":"2018-10-25","last_seen":"2026-08-11"}],"transactions":[{"id":9211162,"accession":"0000947871-26-000783","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-26-000783","line_url":"/filing/0000947871-26-000783","is_derivative":false,"issuer_cik":"0001706399","issuer_name":"Braveheart Bio, Inc.","issuer_ticker":"BRVE","issuer_name_source":null,"issuer_url":"/issuer/0001706399","owner_cik":"0001706399","owner_name":"Chimovits Erez","owner_display_name":"Chimovits Erez","owner_url":"/insider/0001706399","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1940000.0,"shares_display":"1,940,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":34920000.0,"total_display":"34,920,000.00","total_whole":"34,920,000","shares_owned_after":273333.0,"shares_owned_after_display":"273,333","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-08-07","filed_date":"2026-08-11","scope":"insider","n_lines":2},{"id":3150450,"accession":"0000947871-24-000807","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-24-000807","line_url":"/filing/0000947871-24-000807","is_derivative":false,"issuer_cik":"0001706399","issuer_name":"Upstream Bio, Inc.","issuer_ticker":"UPB","issuer_name_source":null,"issuer_url":"/issuer/0001706399","owner_cik":"0001706399","owner_name":"Chimovits Erez","owner_display_name":"Chimovits Erez","owner_url":"/insider/0001706399","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":825000.0,"shares_display":"825,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":14025000.0,"total_display":"14,025,000.00","total_whole":"14,025,000","shares_owned_after":4554873.0,"shares_owned_after_display":"4,554,873","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-15","filed_date":"2024-10-17","scope":"insider","n_lines":2},{"id":2107828,"accession":"0000947871-24-000498","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-24-000498","line_url":"/filing/0000947871-24-000498#line-1","is_derivative":false,"issuer_cik":"0001282930","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001282930","owner_cik":null,"owner_name":"OrbiMed Israel GP Ltd.; GORDON CARL L; OrbiMed Israel BioFund GP Limited Partnership; Chimovits Erez","owner_display_name":"OrbiMed Israel GP Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24344.0,"shares_display":"24,344","price_per_share":0.3812,"price_display":"0.38","price_state":"stated","total_value":9279.9328,"total_display":"9,279.93","total_whole":"9,280","shares_owned_after":13773653.0,"shares_owned_after_display":"13,773,653","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-15","filed_date":"2024-05-20","scope":"insider"},{"id":8620728,"accession":"0000947871-23-000713","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000947871-23-000713","line_url":"/filing/0000947871-23-000713","is_derivative":false,"issuer_cik":"0001055951","issuer_name":"Adicet Bio, Inc.","issuer_ticker":"ACET","issuer_name_source":null,"issuer_url":"/issuer/0001055951","owner_cik":null,"owner_name":"OrbiMed Israel GP II, L.P.; OrbiMed Israel BioFund GP Limited Partnership; ORBIMED ADVISORS LLC; OrbiMed Advisors Israel II Ltd; Chimovits Erez; OrbiMed Israel GP Ltd.; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLC; OrbiMed Capital GP V LLC","owner_display_name":"OrbiMed Israel GP II, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":875000.0,"shares_display":"875,000","price_per_share":2.09,"price_display":"2.09","price_state":"stated","total_value":1828750.0,"total_display":"1,828,750.00","total_whole":"1,828,750","shares_owned_after":5685259.0,"shares_owned_after_display":"5,685,259","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-27","filed_date":"2023-06-29","scope":"insider","n_lines":4},{"id":8310413,"accession":"0000947871-23-000336","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-23-000336","line_url":"/filing/0000947871-23-000336#line-1","is_derivative":false,"issuer_cik":"0001282930","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001282930","owner_cik":null,"owner_name":"OrbiMed Israel GP Ltd.; OrbiMed Israel BioFund GP Limited Partnership; Chimovits Erez; GORDON CARL L","owner_display_name":"OrbiMed Israel GP Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":348000.0,"shares_display":"348,000","price_per_share":0.245,"price_display":"0.24","price_state":"stated","total_value":85260.0,"total_display":"85,260.00","total_whole":"85,260","shares_owned_after":3161489.0,"shares_owned_after_display":"3,161,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-02-27","filed_date":"2023-03-17","scope":"insider"},{"id":3205025,"accession":"0000947871-20-000776","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-20-000776","line_url":"/filing/0000947871-20-000776","is_derivative":false,"issuer_cik":"0001664106","issuer_name":"LogicBio Therapeutics, Inc.","issuer_ticker":"LOGC","issuer_name_source":null,"issuer_url":"/issuer/0001664106","owner_cik":"0001706399","owner_name":"Chimovits Erez","owner_display_name":"Chimovits Erez","owner_url":"/insider/0001706399","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1481482.0,"shares_display":"1,481,482","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":8888892.0,"total_display":"8,888,892.00","total_whole":"8,888,892","shares_owned_after":4126972.0,"shares_owned_after_display":"4,126,972","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-05","scope":"insider","n_lines":3},{"id":7809140,"accession":"0000947871-19-000982","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-19-000982","line_url":"/filing/0000947871-19-000982#line-2","is_derivative":false,"issuer_cik":"0001706399","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001706399","owner_cik":"0001706399","owner_name":"Chimovits Erez","owner_display_name":"Chimovits Erez","owner_url":"/insider/0001706399","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":8.9,"price_display":"8.90","price_state":"stated","total_value":31150.0,"total_display":"31,150.00","total_whole":"31,150","shares_owned_after":2313489.0,"shares_owned_after_display":"2,313,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-19","filed_date":"2019-12-20","scope":"insider"},{"id":7809136,"accession":"0000947871-19-000982","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-19-000982","line_url":"/filing/0000947871-19-000982#line-1","is_derivative":false,"issuer_cik":"0001706399","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001706399","owner_cik":"0001706399","owner_name":"Chimovits Erez","owner_display_name":"Chimovits Erez","owner_url":"/insider/0001706399","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":8.93,"price_display":"8.93","price_state":"stated","total_value":4465.0,"total_display":"4,465.00","total_whole":"4,465","shares_owned_after":2309989.0,"shares_owned_after_display":"2,309,989","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-18","filed_date":"2019-12-20","scope":"insider"},{"id":8635532,"accession":"0000947871-19-000962","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-19-000962","line_url":"/filing/0000947871-19-000962#line-2","is_derivative":false,"issuer_cik":"0001706399","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001706399","owner_cik":"0001706399","owner_name":"Chimovits Erez","owner_display_name":"Chimovits Erez","owner_url":"/insider/0001706399","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5400.0,"shares_display":"5,400","price_per_share":8.92,"price_display":"8.92","price_state":"stated","total_value":48168.0,"total_display":"48,168.00","total_whole":"48,168","shares_owned_after":2309489.0,"shares_owned_after_display":"2,309,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-11","filed_date":"2019-12-12","scope":"insider"},{"id":8635529,"accession":"0000947871-19-000962","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-19-000962","line_url":"/filing/0000947871-19-000962#line-1","is_derivative":false,"issuer_cik":"0001706399","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001706399","owner_cik":"0001706399","owner_name":"Chimovits Erez","owner_display_name":"Chimovits Erez","owner_url":"/insider/0001706399","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3400.0,"shares_display":"3,400","price_per_share":8.75,"price_display":"8.75","price_state":"stated","total_value":29750.0,"total_display":"29,750.00","total_whole":"29,750","shares_owned_after":2304089.0,"shares_owned_after_display":"2,304,089","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-10","filed_date":"2019-12-12","scope":"insider"},{"id":8762844,"accession":"0000947871-19-000947","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000947871-19-000947","line_url":"/filing/0000947871-19-000947#line-3","is_derivative":false,"issuer_cik":"0001706399","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001706399","owner_cik":"0001706399","owner_name":"Chimovits Erez","owner_display_name":"Chimovits Erez","owner_url":"/insider/0001706399","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":8.68,"price_display":"8.68","price_state":"stated","total_value":52080.0,"total_display":"52,080.00","total_whole":"52,080","shares_owned_after":2300689.0,"shares_owned_after_display":"2,300,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-09","filed_date":"2019-12-09","scope":"insider"},{"id":8762841,"accession":"0000947871-19-000947","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000947871-19-000947","line_url":"/filing/0000947871-19-000947#line-2","is_derivative":false,"issuer_cik":"0001706399","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001706399","owner_cik":"0001706399","owner_name":"Chimovits Erez","owner_display_name":"Chimovits Erez","owner_url":"/insider/0001706399","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":6400.0,"total_display":"6,400.00","total_whole":"6,400","shares_owned_after":2294689.0,"shares_owned_after_display":"2,294,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-06","filed_date":"2019-12-09","scope":"insider"},{"id":8762838,"accession":"0000947871-19-000947","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-19-000947","line_url":"/filing/0000947871-19-000947#line-1","is_derivative":false,"issuer_cik":"0001706399","issuer_name":"BiomX Inc.","issuer_ticker":"PHGE","issuer_name_source":null,"issuer_url":"/issuer/0001706399","owner_cik":"0001706399","owner_name":"Chimovits Erez","owner_display_name":"Chimovits Erez","owner_url":"/insider/0001706399","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3400.0,"shares_display":"3,400","price_per_share":7.99,"price_display":"7.99","price_state":"stated","total_value":27166.0,"total_display":"27,166.00","total_whole":"27,166","shares_owned_after":2293889.0,"shares_owned_after_display":"2,293,889","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-12-05","filed_date":"2019-12-09","scope":"insider"},{"id":7776483,"accession":"0000947871-19-000336","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000947871-19-000336","line_url":"/filing/0000947871-19-000336#line-1","is_derivative":false,"issuer_cik":"0001404281","issuer_name":"Novus Therapeutics, Inc.","issuer_ticker":"NVUS","issuer_name_source":null,"issuer_url":"/issuer/0001404281","owner_cik":"0001706399","owner_name":"Chimovits Erez","owner_display_name":"Chimovits Erez","owner_url":"/insider/0001706399","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":646204.0,"shares_display":"646,204","price_per_share":3.1,"price_display":"3.10","price_state":"stated","total_value":2003232.4,"total_display":"2,003,232.40","total_whole":"2,003,232","shares_owned_after":3183314.0,"shares_owned_after_display":"3,183,314","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-02","filed_date":"2019-05-06","scope":"insider"},{"id":6647252,"accession":"0000899243-18-027475","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-18-027475","line_url":"/filing/0000899243-18-027475#line-2","is_derivative":false,"issuer_cik":"0001664106","issuer_name":"LogicBio Therapeutics, Inc.","issuer_ticker":"LOGC","issuer_name_source":null,"issuer_url":"/issuer/0001664106","owner_cik":"0001706399","owner_name":"Chimovits Erez","owner_display_name":"Chimovits Erez","owner_url":"/insider/0001706399","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":490000.0,"shares_display":"490,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":4900000.0,"total_display":"4,900,000.00","total_whole":"4,900,000","shares_owned_after":3487760.0,"shares_owned_after_display":"3,487,760","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-23","filed_date":"2018-10-25","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":16,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0002131524","name":"Braveheart Bio, Inc.","url":"/issuer/0002131524","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2026-08-11","last_seen":"2026-08-11"},{"type":"issuer","type_label":"ISSUER","cik":"0002022626","name":"Upstream Bio, Inc.","url":"/issuer/0002022626","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2024-10-17","last_seen":"2024-10-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001739174","name":"BiomX Inc.","url":"/issuer/0001739174","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2019-12-09","last_seen":"2024-05-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001720580","name":"Adicet Bio, Inc.","url":"/issuer/0001720580","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2023-06-29","last_seen":"2023-06-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001664106","name":"LogicBio Therapeutics, Inc.","url":"/issuer/0001664106","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2018-10-25","last_seen":"2020-10-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001404281","name":"Novus Therapeutics, Inc.","url":"/issuer/0001404281","role":"Director","n_filings":1,"first_seen":"2019-05-06","last_seen":"2019-05-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001706399","retrieved_at":"2026-08-26T12:39:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}